Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells

Journal of Nuclear Medicine

Volumn 51, Issue 9, 2010, Pages 1464-1471

  Plotnik, David A ^a   Emerick, Lindsay E ^a   Krohn, Kenneth A ^a   Unadkat, Jashvant D ^b   Schwartz, Jeffrey L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

3H FLT; 3H FMAU; Nucleoside metabolism; Nucleoside transport; Proliferation

Indexed keywords

1 (2 DEOXY 2 FLUORO BETA DEXTRO ARABINOFURANOSYL) 5 METHYLURACIL H 3; 3' DEOXY 3' FLUOROTHYMIDINE H 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; NUCLEOSIDE TRANSPORTER; RADIOPHARMACEUTICAL AGENT; THYMIDINE H 3; TRACER; UNCLASSIFIED DRUG; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 2'-FLUORO-5-METHYLARABINOSYLURACIL; 3' FLUOROTHYMIDINE; CLEVUDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; THYMIDINE; TRITIUM; URACIL ARABINOSIDE;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; DIFFUSION; DRUG UPTAKE; ENZYME METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NUCLEOSIDE TRANSPORT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR CELL; COMPARATIVE STUDY; KINETICS; METABOLISM; NEOPLASM; PATHOLOGY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ARABINOFURANOSYLURACIL; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL PROLIFERATION; DIDEOXYNUCLEOSIDES; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; HUMANS; KINETICS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; THYMIDINE; TRITIUM;

EID: 77957084543     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.076794     Document Type: Article

References (30)

1. Weber WA, Petersen V, Schmidt B, et al. Positron emission tomography in non-small- cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol. 2003;21:2651-2657. (Pubitemid 46606307)
2. Spence AM, Muzi M, Krohn KA. Molecular imaging of regional brain tumor biology. J Cell Biochem Suppl. 2002;39:25-35.
3. Krohn KA, Mankoff DA, Eary JF. Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol. 2001;41(suppl):96S-103S.
4. 14C]FMAU) in rat prostate tumor cells. Nucl Med Biol. 2000;27:361-368.
5. 76Br-BFU as proliferation markers. J Nucl Med. 2002;43:1688-1698.
6. 18F-FLT and thymidine analogs: promise and pitfalls. J Nucl Med. 2003;44:1432-1434.
7. 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44:1426-1431.
8. Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 2002;43:1210-1217.
9. Perumal M, Pillai RG, Barthel H, et al. Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. Cancer Res. 2006;66: 8558-8564.
10. Paproski RJ, Ng AM, Yao SY, Graham K, Young JD, Cass CE. The role of human nucleoside transporters in uptake of 3′-deoxy-3′- fluorothymidine. Mol Pharmacol. 2008;74:1372-1380.
11. Szkotak AJ, Ng AM, Sawicka J, et al. Regulation of K(+) current in human airway epithelial cells by exogenous and autocrine adenosine. Am J Physiol Cell Physiol. 2001;281:C1991-C2002.
12. Ward JL, Sherali A, Mo ZP, Tse CM. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells: Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem. 2000;275:8375-8381.
13. Ritzel MW, Yao SY, Huang MY, Elliott JF, Cass CE, Young JD. Molecular cloning and functional expression of cDNAs encoding a human Na+- nucleoside cotransporter (hCNT1). Am J Physiol. 1997;272:C707-C714. (Pubitemid 27142601)
14. Huang QQ, Yao SY, Ritzel MW, Paterson AR, Cass CE, Young JD. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem. 1994;269:17757-17760.
15. Cass CE, Young JD, Baldwin SA. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol. 1998;76:761-770.
16. Damaraju VL, Damaraju S, Young JD, et al. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene. 2003;22:7524-7536.
17. Belt JA, Marina NM, Phelps DA, Crawford CR. Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul. 1993;33:235-252.
18. Kong XB, Zhu QY, Vidal PM, et al. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-azido-3′-deoxythymidine. Antimicrob Agents Chemother. 1992;36:808-818.
19. Patil SD, Ngo LY, Unadkat JD. Structure-inhibitory profiles of nucleosides for the human intestinal N1 and N2 Na+-nucleoside transporters. Cancer Chemother Pharmacol. 2000;46:394-402.
20. Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. J Nucl Med. 2003;44:2027-2032.
21. SenGupta DJ, Unadkat JD. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. Biochem Pharmacol. 2004;67:453-458.
22. Hammond JR. Comparative pharmacology of the nitrobenzylthioguanosine- sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells. J Pharmacol Exp Ther. 1991;259:799-807.
23. Wiley JS, Taupin J, Jamieson GP, Snook M, Sawyer WH, Finch LR. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma. J Clin Invest. 1985;75:632-642.
24. Cass CE, Young JD, Baldwin SA, et al. Nucleoside transporters of mammalian cells. Pharm Biotechnol. 1999;12:313-352.
25. Hyde RJ, Cass CE, Young JD, Baldwin SA. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol. 2001;18:53-63.
26. Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab. 2004;5:63-84.
27. del Santo B, Valdes R, Mata J, Felipe A, Casado FJ, Pastor-Anglada M. Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells. Hepatology. 1998;28:1504-1511.
28. Soler C, Garcia-Manteiga J, Valdes R, et al. Macrophages require different nucleoside transport systems for proliferation and activation. FASEB J. 2001;15:1979-1988.
29. Tehrani OS, Douglas KA, Lawhorn-Crews JM, Shields AF. Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2. Eur J Nucl Med Mol Imaging. 2008;35:1480-1488.
30. Wang J, Eriksson S. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2′-deoxy-2′-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity. Antimicrob Agents Chemother. 1996;40:1555-1557.